{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:02:40Z","timestamp":1785402160126,"version":"3.56.0"},"reference-count":37,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2023YFC2705600"],"award-info":[{"award-number":["2023YFC2705600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2023YFC2705601"],"award-info":[{"award-number":["2023YFC2705601"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2023YFC2705603"],"award-info":[{"award-number":["2023YFC2705603"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2022YFC2703702"],"award-info":[{"award-number":["2022YFC2703702"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971344"],"award-info":[{"award-number":["81971344"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171677"],"award-info":[{"award-number":["82171677"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82192864"],"award-info":[{"award-number":["82192864"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901495"],"award-info":[{"award-number":["81901495"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"award":["81971344"],"award-info":[{"award-number":["81971344"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]},{"award":["82171677"],"award-info":[{"award-number":["82171677"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]},{"award":["82192864"],"award-info":[{"award-number":["82192864"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]},{"award":["81901495"],"award-info":[{"award-number":["81901495"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Shanghai Municipal Commission of Science and Technology Program","award":["22S31901500"],"award-info":[{"award-number":["22S31901500"]}]},{"name":"Shanghai Municipal Commission of Science and Technology Program","award":["21Y21901002"],"award-info":[{"award-number":["21Y21901002"]}]},{"name":"Shanghai Municipal Commission of Science and Technology Program","award":["23ZR1408000"],"award-info":[{"award-number":["23ZR1408000"]}]},{"name":"Shanghai Municipal Commission of Health and family planning","award":["2024ZZ2017"],"award-info":[{"award-number":["2024ZZ2017"]}]},{"award":["2024ZZ2017"],"award-info":[{"award-number":["2024ZZ2017"]}],"id":[{"id":"https:\/\/ror.org\/03at7w331","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: Non-invasive prenatal testing (NIPT) for fetal aneuploidy requires accurate trisomy detection together with reliable fetal fraction assessment. This study evaluated the clinical feasibility of a 106-plex digital PCR (dPCR) NIPT assay for trisomies 13, 18, and 21 with internal fetal fraction quantification. Methods: We consecutively recruited 470 women with high-risk singleton pregnancies. Fetal trisomies were detected using dPCR-NIPT and confirmed by invasive prenatal diagnosis. Pregnancies with negative prenatal diagnostic results were followed to birth. Analytical performance and quality control were assessed using trisomic DNA. The euploid cut-off and diagnostic performance were evaluated in two independent maternal plasma sample sets, using invasive diagnosis and clinical outcome as the reference standard. Results: dPCR-NIPT measured fetal fraction irrespective of fetal sex and detected trisomies at fetal fractions \u22653% using 5 ng DNA. A total of 12 of 470 plasma samples failed cell-free DNA quality control and were excluded before dPCR testing. Of the remaining 458 samples, 5 had fetal fractions below 3% and were classified as failed tests, yielding a nonreportable rate of 1.1%. Using a cut-off of 6.9 established in 103 training samples, no false-positive or false-negative trisomy calls were observed in the 350-sample testing set, corresponding to 100% sensitivity (95% confidence interval [CI], 85.18\u2013100%) and 100% specificity (95% CI, 98.88\u2013100%) for 23 confirmed trisomies. Conclusions: This proof-of-principle study supports the feasibility of fetal fraction-informed dPCR-NIPT for trisomy detection in high-risk singleton pregnancies. Larger prospective studies in average-risk and earlier-gestation populations are required.<\/jats:p>","DOI":"10.3390\/diagnostics16111642","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T11:03:27Z","timestamp":1779879807000},"page":"1642","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Fetal Fraction Optimized 106-Plex Digital PCR Assay for Non-Invasive Prenatal Testing of Fetal Trisomy"],"prefix":"10.3390","volume":"16","author":[{"given":"Songchang","family":"Chen","sequence":"first","affiliation":[{"name":"Institute of Reproduction and Development, Shanghai Key Laboratory of Reproduction and Development, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200437, China"},{"name":"Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai 200090, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorui","family":"Luan","sequence":"additional","affiliation":[{"name":"Institute of Reproduction and Development, Shanghai Key Laboratory of Reproduction and Development, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200437, China"},{"name":"Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai 200090, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianling","family":"Cao","sequence":"additional","affiliation":[{"name":"Institute of Reproduction and Development, Shanghai Key Laboratory of Reproduction and Development, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200437, China"},{"name":"Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai 200090, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Liu","sequence":"additional","affiliation":[{"name":"Institute of Reproduction and Development, Shanghai Key Laboratory of Reproduction and Development, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200437, China"},{"name":"Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai 200090, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Reproduction and Development, Shanghai Key Laboratory of Reproduction and Development, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200437, China"},{"name":"Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai 200090, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Shang","sequence":"additional","affiliation":[{"name":"Nanjing Pregene Biotechnology, Nanjing 210047, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiliang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Nanjing Pregene Biotechnology, Nanjing 210047, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"Yang","sequence":"additional","affiliation":[{"name":"Nanjing Pregene Biotechnology, Nanjing 210047, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0433-8909","authenticated-orcid":false,"given":"Chenming","family":"Xu","sequence":"additional","affiliation":[{"name":"Institute of Reproduction and Development, Shanghai Key Laboratory of Reproduction and Development, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200437, China"},{"name":"Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai 200090, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/bdr2.1589","article-title":"National population-based estimates for major birth defects, 2010\u20132014","volume":"111","author":"Mai","year":"2019","journal-title":"Birth Defects Res."},{"key":"ref_2","first-page":"CD012599","article-title":"First and second trimester serum tests with and without first trimester ultrasound tests for Down\u2019s syndrome screening","volume":"3","author":"Alldred","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Xu, D., Zhu, Y., Li, L., Xu, Y., Yan, W., Dai, M., and Gan, L. (2020). Evaluation of Maternal Serum sHLA-G Levels for Trisomy 18 Fetuses Screening at Second Trimester. Front. Genet., 11.","DOI":"10.3389\/fgene.2020.497264"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/1471-0528.14009","article-title":"Performance of prenatal screening using maternal serum and ultrasound markers for Down syndrome in Chinese women: A systematic review and meta-analysis","volume":"123","author":"Tu","year":"2016","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/uog.14636","article-title":"Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: A systematic review and meta-analysis","volume":"45","author":"Akolekar","year":"2015","journal-title":"Ultrasound Obs. Gynecol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/uog.20293","article-title":"Procedure-related risk of miscarriage following chorionic villus sampling and amniocentesis","volume":"54","author":"Beta","year":"2019","journal-title":"Ultrasound Obs. Gynecol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/uog.20353","article-title":"Risk of miscarriage following amniocentesis or chorionic villus sampling: Systematic review of literature and updated meta-analysis","volume":"54","author":"Salomon","year":"2019","journal-title":"Ultrasound Obs. Gynecol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e010002","DOI":"10.1136\/bmjopen-2015-010002","article-title":"Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: A systematic review and meta-analysis","volume":"6","author":"Freeman","year":"2016","journal-title":"BMJ Open"},{"key":"ref_9","unstructured":"Health Quality Ontario (2019). Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment. Ont. Health Technol. Assess. Ser., 19, 1\u2013166."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/aogs.13047","article-title":"Analysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population\u2014A systematic review and meta-analysis","volume":"96","author":"Iwarsson","year":"2017","journal-title":"Acta Obs. Gynecol. Scand."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/1471-0528.14050","article-title":"The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: A systematic review and bivariate meta-analysis","volume":"124","author":"Mackie","year":"2017","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"13116","DOI":"10.1073\/pnas.0705765104","article-title":"Digital PCR for the molecular detection of fetal chromosomal aneuploidy","volume":"104","author":"Lo","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"7576","DOI":"10.1021\/ac0709394","article-title":"Detection of aneuploidy with digital polymerase chain reaction","volume":"79","author":"Fan","year":"2007","journal-title":"Anal. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"543.e1","DOI":"10.1016\/j.ajog.2009.03.002","article-title":"Microfluidic digital PCR enables rapid prenatal diagnosis of fetal aneuploidy","volume":"200","author":"Fan","year":"2009","journal-title":"Am. J. Obs. Gynecol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Nykel, A., Wozniak, R., and Gach, A. (2021). Clinical Validation of Novel Chip-Based Digital PCR Platform for Fetal Aneuploidies Screening. Diagnostics, 11.","DOI":"10.3390\/diagnostics11071131"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"El Khattabi, L.A., Rouillac-Le Sciellour, C., Le Tessier, D., Luscan, A., Coustier, A., Porcher, R., Bhouri, R., Nectoux, J., S\u00e9razin, V., and Quibel, T. (2016). Could Digital PCR Be an Alternative as a Non-Invasive Prenatal Test for Trisomy 21: A Proof of Concept Study. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0155009"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cca.2017.11.015","article-title":"A new approach of digital PCR system for non-invasive prenatal screening of trisomy 21","volume":"476","author":"Lee","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1039\/C8AN02018C","article-title":"A multiplex droplet digital PCR assay for non-invasive prenatal testing of fetal aneuploidies","volume":"144","author":"Tan","year":"2019","journal-title":"Analyst"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Shum, E.Y., Lai, J.H., Li, S., Lee, H.G., Soliman, J., Raol, V.K., Lee, C.K., Fodor, S.P.A., and Fan, H.C. (2022). Next generation digital PCR: High dynamic range single molecule DNA counting via ultra-partitioning. bioRxiv.","DOI":"10.1101\/2022.08.01.502071"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12967-022-03455-y","article-title":"A dPCR-NIPT assay for detections of trisomies 21, 18 and 13 in a single-tube reaction-could it replace serum biochemical tests as a primary maternal plasma screening tool?","volume":"20","author":"Dai","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/AOG.0000000000000363","article-title":"Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort","volume":"124","author":"Pergament","year":"2014","journal-title":"Obs. Gynecol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/uog.15851","article-title":"Screening for trisomies by cell-free DNA testing of maternal blood: Consequences of a failed result","volume":"47","author":"Revello","year":"2016","journal-title":"Ultrasound Obs. Gynecol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1373\/clinchem.2006.074997","article-title":"Hypermethylated RASSF1A in Maternal Plasma: A Universal Fetal DNA Marker that Improves the Reliability of Noninvasive Prenatal Diagnosis","volume":"52","author":"Chan","year":"2006","journal-title":"Clin. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jmoldx.2023.03.002","article-title":"Development of Multiplex Drop-Off Digital PCR Assays for Hotspot Mutation Detection of KRAS, NRAS, BRAF, and PIK3CA in the Plasma of Colorectal Cancer Patients","volume":"25","author":"Yu","year":"2023","journal-title":"J. Mol. Diagn."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1373\/clinchem.2013.206375","article-title":"The digital MIQE guidelines: Minimum Information for Publication of Quantitative Digital PCR Experiments","volume":"59","author":"Huggett","year":"2013","journal-title":"Clin. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/pd.4119","article-title":"Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma","volume":"33","author":"Wang","year":"2013","journal-title":"Prenat. Diagn."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40246-019-0244-0","article-title":"Factors affecting cell-free DNA fetal fraction: Statistical analysis of 13,661 maternal plasmas for non-invasive prenatal screening","volume":"13","author":"Hou","year":"2019","journal-title":"Hum. Genom."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jogoh.2019.07.001","article-title":"The influence of fetal gender and maternal characteristics on fetal cell-free DNA in maternal plasma","volume":"48","author":"Zhao","year":"2019","journal-title":"J. Gynecol. Obs. Hum. Reprod."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/pd.2403","article-title":"The maternal age-specific live birth prevalence of trisomies 13 and 18 compared to trisomy 21 (Down syndrome)","volume":"30","author":"Savva","year":"2010","journal-title":"Prenat. Diagn."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ejhg.2012.94","article-title":"Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: Impact of maternal age and prenatal screening","volume":"21","author":"Loane","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/GIM.0b013e3182368a0e","article-title":"DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study","volume":"13","author":"Palomaki","year":"2011","journal-title":"Genet. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/pd.5528","article-title":"Clinical validation of a novel automated cell-free DNA screening assay for trisomies 21, 13, and 18 in maternal plasma","volume":"39","author":"Ericsson","year":"2019","journal-title":"Prenat. Diagn."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/pd.4103","article-title":"Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y","volume":"33","author":"Nicolaides","year":"2013","journal-title":"Prenat. Diagn."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/pd.1443","article-title":"Maternal age-specific fetal loss rates in Down syndrome pregnancies","volume":"26","author":"Savva","year":"2006","journal-title":"Prenat. Diagn."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0140-6736(21)00682-6","article-title":"Miscarriage matters: The epidemiological, physical, psychological, and economic costs of early pregnancy loss","volume":"397","author":"Quenby","year":"2021","journal-title":"Lancet"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/pd.5111","article-title":"Systematic review and meta-analysis of non-invasive prenatal DNA testing for trisomy 21: Implications for implementation in China","volume":"37","author":"Jin","year":"2017","journal-title":"Prenat. Diagn."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1373\/clinchem.2011.162958","article-title":"Primer Sequence Disclosure: A Clarification of the MIQE Guidelines","volume":"57","author":"Bustin","year":"2011","journal-title":"Clin. Chem."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/11\/1642\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:15:29Z","timestamp":1780028129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/11\/1642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":37,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["diagnostics16111642"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16111642","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]}}}